Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.

Disease-Free Survival Humans Meningeal Neoplasms / metabolism Meningioma / metabolism Receptors, Somatostatin / metabolism Treatment Failure
peptide receptor radionuclide therapy progressive meningioma somatostatin receptor treatment-refractory meningioma

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
04 2021
Historique:
received: 14 05 2020
accepted: 29 07 2020
pubmed: 30 8 2020
medline: 12 5 2021
entrez: 30 8 2020
Statut: ppublish

Résumé

Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT) represents a promising approach for treatment-refractory meningiomas.

Identifiants

DOI: 10.2967/jnumed.120.249607 PMID: 32859705
pubmed: 32859705
pii: jnumed.120.249607
doi: 10.2967/jnumed.120.249607
doi:

Substances chimiques

Receptors, Somatostatin 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-513

Subventions

Organisme : NCI NIH HHS
ID : P30 CA062203
Pays : United States

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Christian Mirian (C)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Christian.mirian.larsen@regionh.dk.
Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland.

Anne Katrine Duun-Henriksen (AK)

Statistics and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark.

Andrea Maier (A)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Maria Møller Pedersen (MM)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Lasse Rehné Jensen (LR)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Asma Bashir (A)

Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark.

Thomas Graillon (T)

APHM, Department of Neurosurgery, La Timone Hospital, Marseille, France.

Maya Hrachova (M)

Department of Neurology, UC Irvine Medical Center, Irvine, California.

Daniela Bota (D)

Department of Neurology, UC Irvine Medical Center, Irvine, California.
Department of Neurosurgery, UC Irvine Medical Center, Irvine, California.

Martjin van Essen (M)

Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Petar Spanjol (P)

Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland.

Christian Kreis (C)

Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland.

Ian Law (I)

Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark.

Helle Broholm (H)

Department of Neuropathology, Copenhagen University Hospital, Copenhagen, Denmark.

Lars Poulsgaard (L)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Kåre Fugleholm (K)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Morten Ziebell (M)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Tina Munch (T)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; and.

Martin A Walter (MA)

Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland.

Tiit Mathiesen (T)

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Survie sans rechute › Somatostatin Receptor-Targeted Radiopeptide...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Somatostatin Receptor-Targeted Radiopeptide...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs des méninges › Somatostatin Receptor-Targeted Radiopeptide...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs des méninges › Méningiome › Somatostatin Receptor-Targeted Radiopeptide...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormones hypothalamiques hypophysotropes régulatrices › Récepteur somatostatine › Somatostatin Receptor-Targeted Radiopeptide...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Échec thérapeutique › Somatostatin Receptor-Targeted Radiopeptide...